Work

Phase I trial of a modified vaccinia ankara (MVA) priming vaccine followed by a fowlpox virus (FPV) boosting vaccine modified to express brachyury and costimulatory molecules in advanced solid tumors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2640

Authors: Julie Marie Collins, Renee Nicole Donahue, Yo-Ting Tsai, Claudia Palena, Jennifer L. Marte, Ravi Amrit Madan, Fatima Karzai, Christopher Ryan Heery, Julius Strauss, Margaret Elena Gatti-Mays, Lisa M. Cordes, Jeffrey Schlom, James L. Gulley, Marijo Bilusic

Institutions: National Cancer Institute, National Institutes of Health, Bavarian Nordic (United States), Georgetown University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947567971

Cites:

Cited by:

Related to: 10